Why Subscribe?
Identify potential biotech parnters by matching relevant research programs to your expertise. By keeping an eye on the development stages, you can make contact at the right time through our LinkedIn integration tool or company e-mail.
Keep an up-to-date view on the microbiome drug landscape to help with IP decisions, benchmarking, current analytics to approach investors as well as identify potential collaborations and partnerships.
Keep an up-to-date view on the microbiome pharmaceutical landscape, scout new investments, technologies and strategic partnerships as well as identify niches and trends. Gain access to our bi-annual market reports.
See which and how many drugs are being developed for the specific indications, the stage of their development and modality.
Take a look inside...
What people say about it
"The Microbiome Drug Database has been a useful tool for Biose’s business development. The ability to filter through companies by development stage and therapeutic modality allows us to quickly identify suitable clients in-line with our growth strategy"
Richard Ellis
Business Development Director,
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Curabitur aliquet quam id dui posuere blandit Cras ultricies ligula sed magna dictum porta.
Vivamus magna
Lacinia eget
Company subscriptions to the Microbiome Drug Database cost €4950 annually. Subscriptions are not automatically renewed and include up to 5x passes per organisation.